Nuclear Factor I‐B Delays Liver Fibrosis by Inhibiting Chemokine Ligand 5 Transcription
Authors:
Open Access
- 23 December 2025
- journal article
- Published by Wiley in Advanced Science
- Vol. 13 (13) , e11311
Abstract
Metabolic dysfunction‐associated steatohepatitis (MASH) is a significant contributor to liver fibrosis due to hepatic stellate cells (HSCs) activation. The anti‐apoptotic gene Nuclear Factor I‐B (NFIB) has been implicated in regulating cell proliferation and differentiation in the context of liver injury. However, its role in HSCs differentiation remains unclear. Our study reveals NFIB as the most markedly down‐regulated transcription factor during HSCs activation, as evidenced by single‐cell sequencing analysis of liver fibrosis. Clinical examination of liver tissues from MASH fibrosis patients corroborated diminished NFIB expression in HSCs across varying fibrosis stages. Using a murine model of liver fibrosis induced by a choline‐deficient, amino acid‐restricted high‐fat diet (CDAHFD) and carbon tetrachloride (CCl 4 ) exposure, we observed reduced fibrosis levels following NFIB overexpression. Subsequent RNA sequencing elucidated the mechanism by which NFIB operates in liver fibrosis. Specifically, NFIB is found to directly interact with the promoter region of the chemokine C─C motif ligand 5 (CCL5), suppressing its expression and thereby mitigating liver fibrosis by inhibiting oxidative stress. These findings uncover a previously unrecognized role of the NFIB/CCL5 axis in liver fibrosis progression, presenting a novel therapeutic target for liver fibrosis management.Keywords
Funding Information
- Natural Science Foundation of Jiangsu Province (BK20231118)
- Natural Science Foundation of Yunnan Province (202201AY070001‐042)
This publication has 52 references indexed in Scilit:
- PIN 1 is a novel interaction partner and a negative upstream regulator of the transcription factor NFIBFEBS Letters, 2024
- MiR-326-mediated overexpression of NFIB offsets TGF-β induced epithelial to mesenchymal transition and reverses lung fibrosisCellular and Molecular Life Sciences, 2023
- CD11b+CD43hiLy6Clo splenocyte‐derived macrophages exacerbate liver fibrosis via spleen–liver axisHepatology, 2023
- Hepatocyte‐derived MASP1‐enriched small extracellular vesicles activate HSCs to promote liver fibrosisHepatology, 2022
- Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver FibrosisHepatology, 2020
- Interleukin‐22 Ameliorates Neutrophil‐Driven Nonalcoholic Steatohepatitis Through Multiple TargetsHepatology, 2020
- Variants in nuclear factor I genes influence growth and developmentAmerican Journal of Medical Genetics Part C: Seminars in Medical Genetics, 2019
- Hepatitis C virus–induced CCL5 secretion from macrophages activates hepatic stellate cellsHepatology, 2017
- Developmental transcription factor NFIB is a putative target of oncofetal miRNAs and is associated with tumour aggressiveness in lung adenocarcinomaThe Journal of Pathology, 2016
- Hepatic Stellate Cells and Liver FibrosisComprehensive Physiology, 2013